Topology-Based Biomarkers Outperform Traditional Methods in Predicting Breast Cancer Survival
核心洞察
Columbia University researchers developed topology-based biomarkers that transform visual tissue patterns into quantitative measurements for breast cancer (搜索) prognosis.
Higher topology scores, indicating more organized tissue structure, were strongly associated with longer survival and more favorable outcomes across diverse patient populations.
The biomarkers outperformed conventional approaches and remained predictive across both non-Hispanic Black and non-Hispanic white patient groups, showing less variability than traditional methods.
A new computational approach that transforms the visual patterns pathologists have relied on for decades into precise quantitative measurements could significantly improve how clinicians predict breast cancer (搜索) outcomes and select therapies, according to research from Columbia University and collaborators published in Cancer Research.
The study applied mathematical tools from topology—specifically a method called persistent homology—to digital images of breast cancer (搜索) tissue, generating continuous numerical scores that captured the organizational structure of tumors with unprecedented precision.
"Pathologists have been looking at disorganized structure for years," said Kevin Gardner, MD, PhD, chair of the department of pathology and cell biology at Columbia University Irving Medical Center and senior author of the study. "What topology allows us to do is move from something subjective to something quantitative."
From Visual Assessment to Quantitative Measurement
Cancer is characteristically marked by a loss of normal tissue organization. Healthy tissue forms structured, gland-like architectures, while malignant tissue becomes increasingly chaotic and disordered. Traditionally, pathologists assess these changes qualitatively through tumor grading systems—assigning a low grade to slower-growing cancers that resemble normal cells and a higher grade to faster-growing, more aggressive cancers.
The Columbia team took a fundamentally different approach. Using multiplex immunofluorescence imaging, they mapped the precise coordinates of tumor cells, immune cells, and PD-L1 (搜索) expression within tumor samples from more than 550 breast cancer (搜索) patients drawn from a racially diverse cohort in North Carolina. Rather than simply identifying which cells were present, the method examined how tumor cells and immune cells were spatially organized relative to one another.
The result was a set of topology-based biomarkers capable of quantifying tissue architecture on a continuous scale.
Superior Predictive Performance Across Populations
The study found that these topology-based measurements strongly predicted breast cancer (搜索) survival. Higher topology scores—indicating more organized tissue structure—were associated with longer survival and more favorable outcomes, outperforming multiple conventional approaches to grading and diagnosis.
Critically, the biomarkers demonstrated consistent performance across racial and ethnic groups. Traditional biomarkers, including some gene and protein markers, often show variability in how accurately they predict outcomes across different patient populations. The topology-based biomarkers, by contrast, remained highly predictive across both non-Hispanic Black and non-Hispanic white patient groups.
"This work suggests that the spatial organization of the tumor contains important biological information that conventional biomarkers may miss," said Jasmine McDonald, PhD, associate professor of epidemiology at Columbia and an author of the study.
The researchers further integrated the topology measurements with gene expression data to create topology-derived gene signatures, which successfully predicted response to therapy in independent breast cancer (搜索) clinical trial datasets.
Biological Pathways Underlying Tumor Disorganization
Beyond prediction, the study uncovered biological pathways associated with tumor disorganization. The researchers identified links between low topology scores and pathways involved in metabolism, immune suppression, and epithelial-to-mesenchymal transition—a process associated with cancer invasion and metastasis.
One particularly notable finding involved IL4-I1 (搜索), a metabolic enzyme connected to aryl hydrocarbon receptor signaling, which has previously been implicated in tumor progression and immune regulation. These findings suggest that structural changes within tumors may be closely tied to metabolic and immune processes within the tumor microenvironment.
Toward Broader Clinical Application
The current study relied on multiplex immunofluorescence imaging, but the researchers are already working toward applying similar topology methods to standard pathology slides routinely used in clinics worldwide. Because those stains are inexpensive and already widely used, the approach could eventually help expand access to advanced cancer diagnostics far beyond major academic medical centers.
"Once you can put a number on an image, there's a lot you can do," Gardner said. "You can integrate it with genomics, clinical information, and other data streams to make more predictive models."
In the future, researchers envision tissue samples being digitally scanned and analyzed using computational algorithms trained to recognize structural patterns linked to prognosis and therapeutic response—potentially making sophisticated pathology analysis more accessible in low-resource or geographically remote settings.
"For more than a century, pathology has relied on recognizing patterns visually," Gardner said. "What's exciting now is that we can begin to mathematically define those patterns and use them predictively. The long-term potential is that advanced cancer diagnostics could become faster, more quantitative, more accurate, and far more broadly accessible than they are today."
While additional validation and clinical studies will be needed before the approach reaches routine clinical use, the findings highlight the potential for topology-based biomarkers to improve prognostic accuracy, deepen understanding of tumor biology, and predict therapeutic response in ways that are more consistent across diverse patient populations.